AXOLOTNasdaq StockholmWaste ManagementIFRS · SEK

Axolot Solutions Holding

Axolot Solutions Holding AB is a Swedish environmental technology company focused on industrial water treatment. Through its group structure, it develops and commercializes a patented process based on electrocoagulation and flotation for treating process water and enabling water recirculation.

Operating profit (EBIT)-5.9m SEK
−93.0 %y/y

Fiscal year 2025 · change from previous year

Development 2022–2025

-7.5-5.0-2.50.02.55.07.5m SEK2022: 0.38 m SEK2022: EBIT -4.9 m SEK20222023: 5.8 m SEK2023: EBIT -4.0 m SEK20232024: EBIT -3.1 m SEK20242025: EBIT -5.9 m SEK2025-5.9
RevenueOperating profit (EBIT)

Business

Share of revenue
Industrial water treatment systems45 %

Patented AxoPur® systems for treating industrial process water and wastewater.

Electrocoagulation technology20 %

Core treatment technology that destabilizes and removes contaminants from water.

Flotation and separation solutions15 %

Equipment and process steps used to separate pollutants, solids, and water.

Turnkey partner projects20 %

Integrated project delivery with local or regional partners for industrial clients.

Customers

Axolot sells to industrial operators that need to treat process water, reduce contaminants, and enable reuse of water in production. Its customers are typically companies with wastewater streams that are difficult or costly to handle using conventional methods, and it often works through local or regional partners rather than a direct mass-market model.

Industrial manufacturing and process industries

Buy treatment systems to manage process water, remove contaminants, and support reuse in operations.

Environmental technology partners

Local or regional partners that market, sell, and deliver Axolot-based solutions to end users.

Project-based industrial customers

Buy tailored water treatment projects for specific sites, plants, or effluent challenges.

Operators with water-reuse needs

Adopt AxoPur to reduce freshwater use and improve internal recirculation of water.

Strategy

Axolot’s strategy is to commercialize AxoPur through partnerships with local and regional players that already have customer access and market knowledge. The company is positioning itself as a provider of complete industrial water-treatment solutions, with an emphasis on scalable market entry, reference installations, and partner-led distribution.

Partner-led commercializationShort term

Local partners reduce market-entry friction and provide customer access in fragmented industrial markets.

Broaden international market reachMedium term

Industrial water treatment demand is geographically dispersed and often project-based, so partner networks are essential for scale.

Build reference installations and credibilityMedium term

Industrial buyers typically require proof of performance before adopting new treatment technologies.

Geography

Axolot is headquartered in Sweden and has disclosed operations in Sweden and Norway through its group structure and partner relationships. The company also references broader international commercialization through partners, including markets such as the Middle East and Japan, which indicates a geographically distributed sales model rather than a single domestic market.

Risks

Axolot’s business depends on winning project-based industrial customers and converting technical performance into repeatable commercial adoption, which creates execution and sales-cycle risk. The company is also exposed to partner concentration, technology validation risk, and the usual risks of small environmental technology firms, including financing needs, customer delays, and competitive alternatives.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Financing and scale-up risk1Technology adoption risk2Project timing and customer delay risk4
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Financing and scale-up riskImpact: HighLikelihood: High

    Small environmental technology companies often need external funding before commercial scale is reached.

    Exposure: Corporate operations and expansion

  2. Technology adoption riskImpact: HighLikelihood: Medium

    Industrial customers may require extensive testing and proof before adopting a new treatment process.

    Exposure: AxoPur and electrocoagulation solutions

  3. Partner dependenceImpact: High

    The go-to-market model relies on local or regional partners to access customers and execute sales.

    Exposure: Selected markets and partner-led commercialization

  4. Project timing and customer delay riskImpact: MediumLikelihood: Medium

    Revenue and deployment can be delayed by permitting, procurement, or site-readiness issues.

    Exposure: Turnkey industrial projects

Accounting

Judgemental items
Capitalized development costs and patents

The company holds development-related intangible assets that must be assessed for recoverability.

Impact: Can affect asset values and impairment charges

Revenue recognition on project deliveries

Industrial water-treatment projects may involve milestones, installation, and acceptance criteria.

Impact: Can shift revenue between periods

Inventory valuation

Treatment equipment and components may need write-downs if demand or project timing changes.

Impact: Can affect gross assets and operating results

Equity-accounted or strategic investments

The company has referenced ownership interests in a partner, which may require fair-value or equity-method judgments.

Impact: Can affect balance sheet and income statement

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

Axolot Solutions Holding (XSTO) – Waste Management | Financial Analysis – Clarifo